Xiaoyan Bai | Nephrology | Outstanding Scientist Award

Published on by China Scientist

Prof. Dr. Xiaoyan Bai | Nephrology | Outstanding Scientist Award

Professor Xiaoyan Bai is a Professor of Nephrology at Guangdong Provincial People’s Hospital and Southern Medical University, where she also serves as Vice Dean of the Graduate School at Guangdong Medical University. She earned her medical and doctoral degrees in Pathology and completed her postdoctoral training at the University of Texas Southwestern Medical Center in the United States. Her research focuses on the molecular mechanisms of diabetic nephropathy, podocyte injury, and renal fibrosis, with a strong emphasis on translating discoveries into therapeutic strategies. She has published widely in high-impact journals, received provincial recognition for scientific advancement, and leads multiple national research projects while mentoring future scholars.

Prof. Dr. Xiaoyan Bai | Guangdong Provincial People’s Hospital | China

Profile

SCOPUS

Education

  • Professor Xiaoyan Bai holds both a Doctor of Medicine and a Doctor of Philosophy in Pathology. She further advanced her academic journey by completing postdoctoral training at the University of Texas Southwestern Medical Center in the United States. Her strong educational foundation in clinical and molecular medicine has guided her research in nephrology, particularly in the fields of diabetic kidney disease and renal fibrosis.

Experience

  • She currently serves as a Professor of Nephrology at Guangdong Provincial People’s Hospital and Guangdong Academy of Medical Sciences, affiliated with Southern Medical University. In addition, she holds the position of Vice Dean at the Graduate School of Guangdong Medical University. Beyond her academic appointments, she actively engages in leading and supervising doctoral students while managing key national and provincial research projects. Her experience is also enriched through collaborations with international institutions, such as UT Southwestern Medical Center, and through her involvement in peer review for leading journals.

Awards and Recognition

  • Professor Bai has been recognized with significant scientific honors, including the First Prize for Scientific and Technological Advancement from Guangdong Province. This award highlights her impactful contributions to understanding the mechanisms underlying diabetic nephropathy and kidney fibrosis.

Skills and Expertise

  • She possesses expertise in experimental pathology, molecular biology, and translational nephrology research. Her skills extend to leading large-scale research projects, supervising postgraduate training, and publishing in high-impact international journals. Additionally, she has experience in industry collaborations, patent development, and academic writing. Her editorial contributions and peer-review activities for international journals also demonstrate her critical evaluation skills and leadership in the field of kidney disease research.

Research Focus 

  • Her primary research interests center on the molecular mechanisms of diabetic nephropathy, podocyte injury, renal tubulointerstitial fibrosis, and hypertensive kidney damage. She explores novel therapeutic pathways and potential drug targets, with a strong emphasis on bridging molecular mechanisms to clinical treatment strategies.

Publications

  • Flot2 protects against podocyte injury by maintaining the stability of synaptopodin in diabetic nephropathy,  Metabolism: Clinical and Experimental, 2025

  • Effectiveness and safety of finerenone in membranous nephropathy patients: a retrospective, real-world study, International Urology and Nephrology, 2025

  • The roles and functions of TMEM protein family members in cancers, cardiovascular and kidney diseases (Review), [Journal not shown in preview], 2025

  • Single-Cell Dissection of the Biological Function and Molecular Features Underlying the Micropeptide LSMEM1 in Kidney, Advanced Science, 2025

  • Single-cell transcriptome atlas in C57BL/6 mice encodes morphological phenotypes in the aging kidneys, BMC Nephrology, 2024

Conclusion

  • Professor Xiaoyan Bai stands out as a visionary leader in nephrology whose research has advanced the understanding of diabetic nephropathy, renal fibrosis, and kidney injury mechanisms. Her combination of scientific innovation, impactful publications, and commitment to mentorship and collaboration makes her a strong contender for the Research for Outstanding Scientist Award. With her continued focus on translational medicine and international engagement, she is well-positioned to shape the future of kidney disease research and improve patient outcomes worldwide.

Yuan-yuan Qi | Nephrology | Best Researcher Award

Published on by China Scientist

Dr. Yuan-yuan Qi | Nephrology | Best Researcher Award

 Funded Research Projects:

  • Her projects funded by the National Science Foundation of China and the Henan Natural Science Foundation reflect her ability to secure significant grants, demonstrating her research’s importance and potential impact. Additionally, her involvement in the Henan Provincial Talent Training Program indicates her role as a key contributor to innovation in health science and nephrology.
Dr. Yuan-yuan Qi, The First Affiliated Hospital of Zhengzhou University, China

Profile

Scopus

OrcID

🌱EARLY ACADEMIC PURSUITS

  • Yuan-yuan Qi, a distinguished Associate Chief Physician, embarked on her academic journey at Peking University, where she obtained her Ph.D. With a strong foundation in medicine, she quickly demonstrated a passion for research and clinical practice, especially in the field of autoimmune diseases affecting the kidneys.

💼 PROFESSIONAL ENDEAVORS

  • Currently serving at the First Affiliated Hospital of Zhengzhou University, Yuan-yuan Qi holds a crucial role in the Department of Nephrology. Her clinical expertise and research prowess are dedicated to understanding and treating autoimmune kidney diseases, including systemic lupus erythematosus and lupus nephritis. In addition to her role at the hospital, she actively contributes to the Nephrology Physicians’ Association of Henan Province as the Deputy Director of the First Youth Committee and holds a young committee membership in the Henan Renal Pathology Society.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS 

  • Yuan-yuan Qi’s research is highly specialized, focusing on systemic lupus erythematosus, lupus nephritis, and other autoimmune kidney disorders. Her studies delve into the pathophysiology and treatment options for these complex diseases, addressing both clinical and molecular aspects. With a publication record that includes prestigious journals, such as Annals of the Rheumatic Diseases, Arthritis & Rheumatology, and Cell Death & Disease, her work is recognized for its significant impact on the field of nephrology.

 📚 ACADEMIC CITES 

  • The research conducted by Dr. Qi holds substantial weight in the academic realm, with a high citation index that underlines her influence. Her work’s consistent referencing by peers highlights her role in advancing the understanding of nephrology and autoimmune diseases, contributing to both national and international research dialogues.

🌐 PROFESSIONAL MEMBERSHIPS AND LEADERSHIP ROLES

  • Dr. Yuan-yuan Qi holds key positions in prominent nephrology associations, highlighting her leadership within the medical community. She serves as the Deputy Director of the First Youth Committee of the Nephrology Physicians’ Association of Henan Province and is a Young Committee Member of the Henan Renal Pathology Society. These roles reflect her commitment to advancing nephrology, fostering professional growth, and collaborating with other experts to drive innovative research and clinical practices.

🏥 CLINICAL EXPERTISE AND PATIENT-CENTERED CARE

  • As an Associate Chief Physician at the First Affiliated Hospital of Zhengzhou University, Dr. Qi combines her research insights with patient-centered clinical care. She specializes in diagnosing and managing autoimmune kidney diseases, particularly systemic lupus erythematosus and lupus nephritis. Her clinical approach is deeply informed by her research, enabling her to deliver personalized, effective treatments that improve patient outcomes and quality of life.

💰 RESEARCH FUNDING AND GRANT SUPPORT

  • Dr. Qi’s research is well-supported by prestigious funding sources, including the National Science Foundation of China (grant numbers 82470752 and 81900643) and the Henan Natural Science Foundation (grant number 242300421275). She also participates in Henan’s Provincial Talent Training Program for Young and Middle-aged Health and Wellness Science and Technology Innovation (grant number YQRC2024010). These grants underscore her research’s significance, supporting her ongoing work to explore and address autoimmune kidney diseases.

🏆 AWARDS AND RECOGNITIONS

  • Dr. Qi’s contributions have earned her respect and recognition within the nephrology field. Her impactful research and clinical expertise have been acknowledged by her peers, establishing her as an influential voice in nephrology and a leading figure in autoimmune disease research. Through her work, she continues to elevate standards of care and advance knowledge, earning a reputation for excellence in both research and clinical practice.

🌍 IMPACT AND INFLUENCE

  • With 16 SCI-indexed publications as the first or corresponding author, Dr. Qi’s work has amassed over 140 total impact factor points, demonstrating her research’s reach and relevance. Her publications are cited 135 times, reflecting the scientific community’s acknowledgment of her contributions. Her work has advanced knowledge in nephrology, offering insights into autoimmune mechanisms and improving treatment frameworks for patients suffering from severe kidney diseases.

🌟 LEGACY AND FUTURE AND CONTRIBUTIONS

  • Dr. Qi’s ongoing research and commitment to innovation position her as a forward-thinking leader in nephrology. Through her involvement in projects funded by the National Science Foundation of China, the Henan Natural Science Foundation, and Henan’s Young and Middle-aged Talent Training Program, she continues to push the boundaries of nephrology research. Her future work promises further contributions to the understanding of autoimmune kidney diseases, enhancing treatment protocols and patient outcomes.

📄Publications

  • Unveiling biomarkers and therapeutic targets in IgA nephropathy through large-scale blood transcriptome analysis
    Authors: Gan, T., Qu, L.-X., Qu, S., Peng, Y.-J., Zhou, X.-J.
    Journal: International Immunopharmacology, 2024, 132, 111905
  • A cluster of type I interferon-regulated genes associates with disease activity and prognosis in patients with IgA nephropathy
    Authors: Qu, S., Gan, T., Wang, Y.-N., Zhang, H., Zhou, X.-J.
    Journal: International Immunopharmacology, 2024, 131, 111920
  • Clinical features and prognosis of patients with anti-GBM disease combined with mesangial IgA deposition
    Authors: Ning, W., Zhao, Y.-F., Liu, Y.-R., Qi, Y.-Y., Zhao, Z.-Z.
    Journal: Frontiers in Immunology, 2024, 15, 1373581
  • KLF2 enhancer variant rs4808485 increases lupus risk by modulating inflammasome machinery and cellular homoeostasis
    Authors: Singh, M.K., Rallabandi, H.R., Zhou, X.-J., Looger, L.L., Nath, S.K.
    Journal: Annals of the Rheumatic Diseases, 2024, ard-2023-224953
  •  SGLT2 inhibitors alleviated podocyte damage in lupus nephritis by decreasing inflammation and enhancing autophagy
    Authors: Zhao, X.-Y., Li, S.-S., He, Y.-X., Li, Y.-C., Qi, Y.-Y.
    Journal: Annals of the Rheumatic Diseases, 2023, 82(10), pp. 1328–1340